ArticleTherapeutic advances in respiratory disease

Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study.

Aikaterini Detoraki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.